Nutra Pharma Corp.
NPHC
$0.0003
$0.000.00%
OTC PK
| 09/30/2022 | 06/30/2022 | ||||
|---|---|---|---|---|---|
| Revenue | 20.80% | 307.21% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 20.80% | 307.21% | |||
| Cost of Revenue | -32.40% | 322.22% | |||
| Gross Profit | 130.41% | 279.49% | |||
| SG&A Expenses | -17.80% | 17.24% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -19.88% | 30.52% | |||
| Operating Income | 30.67% | -10.60% | |||
| Income Before Tax | 189.38% | -112.88% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 189.38% | -112.88% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 189.38% | -112.88% | |||
| EBIT | 30.67% | -10.60% | |||
| EBITDA | 31.21% | -10.59% | |||
| EPS Basic | 200.00% | -114.29% | |||
| Normalized Basic EPS | -- | -100.00% | |||
| EPS Diluted | 100.00% | -133.33% | |||
| Normalized Diluted EPS | -- | -100.00% | |||
| Average Basic Shares Outstanding | 1.65% | 1.63% | |||
| Average Diluted Shares Outstanding | 108.83% | -48.47% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||